Capital Health System, Inc. is a clinical research site located in Trenton, New Jersey, United States 08638.
Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.
Capital Health System, Inc. has participated in 3 clinical trials.
Therapeutic areas: Covid19, Necrotizing Soft Tissue Infections, Necrotizing Fasciitis.
Sponsors: Thomas L. Ortel, Atox Bio Ltd.
Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Capital Health System, Inc. has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Capital Health System, Inc. has 3 clinical trials on record. Their work covers Covid19, Necrotizing Soft Tissue Infections, Necrotizing Fasciitis.
Capital Health System, Inc. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.